BR0212199A - Uso de aminometil cromanos substituìdos no tratamento de distúrbios do movimento - Google Patents
Uso de aminometil cromanos substituìdos no tratamento de distúrbios do movimentoInfo
- Publication number
- BR0212199A BR0212199A BR0212199-9A BR0212199A BR0212199A BR 0212199 A BR0212199 A BR 0212199A BR 0212199 A BR0212199 A BR 0212199A BR 0212199 A BR0212199 A BR 0212199A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- substituted
- movement disorders
- aminomethyl
- chromanite
- Prior art date
Links
- 208000016285 Movement disease Diseases 0.000 title abstract 3
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 title abstract 2
- 208000027776 Extrapyramidal disease Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 229940035678 anti-parkinson drug Drugs 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000003176 neuroleptic agent Substances 0.000 abstract 1
- 230000000701 neuroleptic effect Effects 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"USO DE AMINOMETIL CROMANOS SUBSTITUìDOS NO TRATAMENTO DE DISTúRBIOS DO MOVIMENTO". A invenção refere-se a aminometil cromanos substituídos, um de seus isómeros óticos ou sais farmaceuticamente aceitáveis, usados para a produção de um medicamento para o tratamento de efeitos adversos de drogas antiparkinsonianas em distúrbios extrapiramidais do movimento e/ou para a produção de um medicamento para o tratamento de sintomas extrapiramidais (EPS) induzidos por neurolépticos. Um composto preferido é o (-)-(R)-2-{4-[[3,4-dihidro-2H-benzopiran-2-lL)-metil]amino]butil}-1,2-be nzoisotiazol-3-(2H)-on-1,1-dióxido ou um sal fisiologicamente aceitável do mesmo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01121910 | 2001-09-12 | ||
| PCT/EP2002/008912 WO2003022269A1 (en) | 2001-09-12 | 2002-08-09 | Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0212199A true BR0212199A (pt) | 2004-10-05 |
Family
ID=8178618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0212199-9A BR0212199A (pt) | 2001-09-12 | 2002-08-09 | Uso de aminometil cromanos substituìdos no tratamento de distúrbios do movimento |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20040235920A1 (pt) |
| EP (1) | EP1425008B1 (pt) |
| JP (1) | JP2005522410A (pt) |
| KR (1) | KR100886185B1 (pt) |
| CN (1) | CN1303996C (pt) |
| AR (1) | AR036509A1 (pt) |
| AT (1) | ATE341322T1 (pt) |
| AU (1) | AU2002331220B2 (pt) |
| BR (1) | BR0212199A (pt) |
| CA (1) | CA2458628A1 (pt) |
| CY (1) | CY1105868T1 (pt) |
| DE (1) | DE60215203T2 (pt) |
| DK (1) | DK1425008T3 (pt) |
| ES (1) | ES2272771T3 (pt) |
| HU (1) | HUP0401317A3 (pt) |
| MX (1) | MXPA04002304A (pt) |
| MY (1) | MY130522A (pt) |
| PL (1) | PL207146B1 (pt) |
| PT (1) | PT1425008E (pt) |
| RU (1) | RU2320336C2 (pt) |
| SI (1) | SI1425008T1 (pt) |
| WO (1) | WO2003022269A1 (pt) |
| ZA (1) | ZA200402774B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004012659A2 (en) | 2002-08-01 | 2004-02-12 | Nitromed, Inc. | Nitrosated proton pump inhibitors, compositions and methods of use |
| EP1856126A2 (en) | 2005-02-17 | 2007-11-21 | Wyeth a Corporation of the State of Delaware | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| RU2611376C2 (ru) * | 2010-10-15 | 2017-02-21 | Контера Фарма Апс | Фармацевтическая композиция для лечения, профилактики или облегчения двигательных расстройств и ее применение |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4983400A (en) * | 1986-06-16 | 1991-01-08 | Merck & Co., Inc. | Controlled release combination of carbidopa/levodopa |
| SE9303274D0 (sv) | 1993-10-07 | 1993-10-07 | Astra Ab | Novel phenylethyl and phenylproplamines |
| IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
| DE19751949A1 (de) * | 1997-11-24 | 1999-05-27 | Bayer Ag | Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration |
| DE10101917A1 (de) | 2001-01-16 | 2002-07-18 | Bayer Ag | Verwendung von Chromanen |
-
2002
- 2002-08-09 BR BR0212199-9A patent/BR0212199A/pt not_active IP Right Cessation
- 2002-08-09 DE DE60215203T patent/DE60215203T2/de not_active Expired - Lifetime
- 2002-08-09 CN CNB028179285A patent/CN1303996C/zh not_active Expired - Fee Related
- 2002-08-09 AT AT02767352T patent/ATE341322T1/de active
- 2002-08-09 RU RU2004111284/15A patent/RU2320336C2/ru not_active IP Right Cessation
- 2002-08-09 US US10/489,249 patent/US20040235920A1/en not_active Abandoned
- 2002-08-09 PT PT02767352T patent/PT1425008E/pt unknown
- 2002-08-09 PL PL369827A patent/PL207146B1/pl not_active IP Right Cessation
- 2002-08-09 SI SI200230456T patent/SI1425008T1/sl unknown
- 2002-08-09 DK DK02767352T patent/DK1425008T3/da active
- 2002-08-09 KR KR1020047001613A patent/KR100886185B1/ko not_active Expired - Fee Related
- 2002-08-09 EP EP02767352A patent/EP1425008B1/en not_active Expired - Lifetime
- 2002-08-09 CA CA002458628A patent/CA2458628A1/en not_active Abandoned
- 2002-08-09 HU HU0401317A patent/HUP0401317A3/hu unknown
- 2002-08-09 JP JP2003526398A patent/JP2005522410A/ja active Pending
- 2002-08-09 ES ES02767352T patent/ES2272771T3/es not_active Expired - Lifetime
- 2002-08-09 AU AU2002331220A patent/AU2002331220B2/en not_active Ceased
- 2002-08-09 MX MXPA04002304A patent/MXPA04002304A/es active IP Right Grant
- 2002-08-09 WO PCT/EP2002/008912 patent/WO2003022269A1/en not_active Ceased
- 2002-09-10 MY MYPI20023379A patent/MY130522A/en unknown
- 2002-09-11 AR ARP020103436A patent/AR036509A1/es not_active Application Discontinuation
-
2004
- 2004-04-08 ZA ZA200402774A patent/ZA200402774B/en unknown
-
2006
- 2006-12-20 CY CY20061101826T patent/CY1105868T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2272771T3 (es) | 2007-05-01 |
| JP2005522410A (ja) | 2005-07-28 |
| CN1303996C (zh) | 2007-03-14 |
| HUP0401317A3 (en) | 2007-05-29 |
| ATE341322T1 (de) | 2006-10-15 |
| SI1425008T1 (sl) | 2007-02-28 |
| WO2003022269A1 (en) | 2003-03-20 |
| KR100886185B1 (ko) | 2009-02-27 |
| MY130522A (en) | 2007-06-29 |
| CN1555259A (zh) | 2004-12-15 |
| DK1425008T3 (da) | 2007-01-15 |
| DE60215203T2 (de) | 2007-10-18 |
| ZA200402774B (en) | 2005-01-13 |
| HUP0401317A2 (en) | 2004-10-28 |
| PL207146B1 (pl) | 2010-11-30 |
| PL369827A1 (en) | 2005-05-02 |
| KR20040043175A (ko) | 2004-05-22 |
| US20040235920A1 (en) | 2004-11-25 |
| PT1425008E (pt) | 2007-01-31 |
| EP1425008B1 (en) | 2006-10-04 |
| RU2320336C2 (ru) | 2008-03-27 |
| AU2002331220B2 (en) | 2007-06-07 |
| RU2004111284A (ru) | 2005-05-10 |
| DE60215203D1 (de) | 2006-11-16 |
| CY1105868T1 (el) | 2011-02-02 |
| MXPA04002304A (es) | 2004-06-29 |
| CA2458628A1 (en) | 2003-03-20 |
| AR036509A1 (es) | 2004-09-15 |
| EP1425008A1 (en) | 2004-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0209468A (pt) | Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar | |
| BR0009864A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças, para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e para o tratamento e/ou prevenção de diabete e/ou obesidade, e, uso de um composto | |
| BR0213242A (pt) | Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto | |
| BRPI0407618A (pt) | derivados de tiazole amino substituidos com cicloalquilo contendo n e composições farmacêuticas para inibição da proliferação celular e métodos para a sua utilização | |
| BR0308814A (pt) | Aminoácidos com afinidade para a proteìna-alfa2gama | |
| BR0111034A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou doenças inflamatórias, para o tratamento e/ou profilaxia de osteoporose e para o tratamento de doenças relacionadas à aids | |
| BR0108870A (pt) | Sais cloridrato de 5-[4-[2-(n-metil-n-(2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona | |
| BR0112395A (pt) | Derivados de benzotiazol | |
| BR0307050A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, sal farmaceuticamente aceitável, e, uso de um composto ou sal | |
| BR0212477A (pt) | 7-aza[2.2.1] bicicloheptanos substituìdos para o tratamento de doenças | |
| BR0111913A (pt) | Análogos de gabapentina para distúrbios do sono | |
| BR0112582A (pt) | Sulfonamidas de ciclilamina como agonistas de receptores beta-3 adrenérgicos | |
| BR0113590A (pt) | 7-oxo-piridopirimidinas | |
| DK1383752T3 (da) | Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser | |
| BRPI0408295A (pt) | uso de um composto | |
| BR0314843A (pt) | Novo composto | |
| BR0212199A (pt) | Uso de aminometil cromanos substituìdos no tratamento de distúrbios do movimento | |
| BR0211358A (pt) | Uso do composto de 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-croman o e seus sais fisiologicamente aceitáveis | |
| BRPI0409217A (pt) | derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona | |
| BR0318659A (pt) | derivados de prolina usados como ingredientes farmacêuticos ativos no tratamento de tumores | |
| BR0109119A (pt) | Uso de (r)-(-)-2-[5-(4-fluorofenil)-3-piridilmetil-aminometil]-cr omano e seus sais fisiologicamente aceitáveis | |
| BRPI0607214B8 (pt) | derivados de 2-(4-cianofenilamino)pirimidina inibidores de hiv, composição farmacêutica que os compreende e seus processos de preparação | |
| PA8483301A1 (es) | Concentrado oral de sertralina | |
| MXPA04002492A (es) | Uso novedoso de aminometil cromanos sustituidos. | |
| BR0015024A (pt) | Aplicação de carbinóis substituìdos por 2-imidazolila para a preparação de um medicamento para o tratamento ou profilaxia de doenças provocadas por estados isquêmicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DA INT.CL: A61K 31/15, A61K 31/195, A61K 31/353, A61K 31/425, A61K 31/428, A61P 25/00, A61P 25/14, A61P 25/16, A61P 25/18, C07D 417/12 Ipc: A61K 31/15 (2006.01), A61K 31/195 (2006.01), A61K |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2162 DE 12/06/2012. |